Protein Aggregates in Heterozygous Alpha-1 Antitrypsin Phenotype Is a Marker for Progressive Disease
George W Marek1, Harmeet Malhi1
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Gastro Hep Advances
|December 9, 2025
Summary
Alpha 1 antitrypsin deficiency (AATD) in heterozygous MZ individuals shows increased liver stiffness and fibrosis. Periodic acid-Schiff positive diastase resistant (PAS-D) globules in biopsies indicate advanced disease and reduced survival.
Area of Science:
- Genetics
- Hepatology
- Pathology
Background:
- Alpha 1 antitrypsin deficiency (AATD) is a genetic disorder linked to SERPINA1 gene mutations.
- AATD can lead to significant liver disease, with varying severity based on genetic Z allele presence.
Purpose of the Study:
- To investigate the impact of heterozygous Pi*Z (MZ) alleles on liver disease progression in AATD.
- To identify histopathologic features associated with liver disease severity and outcomes in MZ individuals.
Main Methods:
- Utilized data from the Mayo Data Explorer, including elastography and pathology reports.
- Analyzed clinical data, histopathological findings (PAS-D globules), and transplant-free survival in MZ individuals.
Main Results:
- MZ individuals exhibited higher liver stiffness and advanced fibrosis compared to MM individuals.
- Periodic acid-Schiff positive diastase resistant (PAS-D) globules were found in 28% of MZ biopsies, correlating with advanced fibrosis.
- PAS-D globules, age, and advanced fibrosis independently predicted decreased transplant-free survival.
Conclusions:
- Heterozygous MZ alleles are associated with increased liver stiffness and fibrosis.
- The presence of PAS-D globules in liver biopsies is a significant predictor of poorer outcomes in AATD patients.
- Findings suggest a need for targeted therapies for MZ individuals with AATD-related liver disease.
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K


